Your browser doesn't support javascript.
loading
MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.
Wu, L M; Zhang, F; Xie, H Y; Xu, X; Chen, Q X; Yin, S Y; Liu, X C; Zhou, L; Xu, X B; Sun, Y L; Zheng, S S.
Affiliation
  • Wu LM; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Clin Genet ; 73(3): 273-8, 2008 Mar.
Article in En | MEDLINE | ID: mdl-18177474
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Polymorphism, Genetic / Liver Transplantation / Promoter Regions, Genetic / Carcinoma, Hepatocellular / Genetic Predisposition to Disease / Matrix Metalloproteinase 2 / Liver Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2008 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Polymorphism, Genetic / Liver Transplantation / Promoter Regions, Genetic / Carcinoma, Hepatocellular / Genetic Predisposition to Disease / Matrix Metalloproteinase 2 / Liver Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2008 Type: Article